Kazia Therapeutics
KZIA
10 hedge funds and large institutions have $903K invested in Kazia Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
647% more capital invested
Capital invested by funds: $121K → $903K (+$782K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
12.88% more ownership
Funds ownership: 0.01% → 12.88% (+13%)
11% more funds holding
Funds holding: 9 → 10 (+1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$541K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$976 |
| 3 |
SS
SBI Securities
Tokyo,
Japan
|
+$467 |
| 4 |
AF
Allworth Financial
Folsom,
California
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$10.4K |
| 2 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$3.36K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$3 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DIG
1
Dauntless Investment Group
Etna,
New Hampshire
| $726K | +$541K | +115,769 | New |
|
2
Barclays
London,
United Kingdom
| $150K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $19K | -$10.4K | -2,228 | -42% |
|
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $3.66K | +$976 | +209 | +55% |
|
|
GI
5
GAMMA Investing
Foster City,
California
| $1.66K | – | – | – |
|
|
AAP
6
Arax Advisory Partners
Denver,
Colorado
| $1.25K | – | – | – |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $627 | +$467 | +100 | New |
|
|
MCM
8
MAI Capital Management
Independence,
Ohio
| $327 | -$3.36K | -719 | -93% |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $62 | – | – | – |
|
|
AF
10
Allworth Financial
Folsom,
California
| $7 | +$5 | +1 | New |
|
|
11
Wells Fargo
San Francisco,
California
| – | -$3 | -1 | Closed |
|
KZIA Hedge Fund Activity: Q2 2025 in Review
10 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q2 2025, worth a combined $903K — up 647% from $121K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KZIA positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Dauntless Investment Group, opening a new position worth an estimated $541K. The largest seller was UBS Group, cutting an estimated $10.4K.
- 10 institutional investors held Kazia Therapeutics (KZIA) as of Q2 2025, up from 9 in Q1 2025.
- Funds reported $903K of Kazia Therapeutics stock for Q2 2025, up 647% quarter-over-quarter.
- 3 funds opened new Kazia Therapeutics positions in Q2 2025 and 2 closed out, a net change of +1 holder.
- The largest Kazia Therapeutics buyer in Q2 2025 was Dauntless Investment Group, an estimated $541K added.
- The largest Kazia Therapeutics seller in Q2 2025 was UBS Group, an estimated $10.4K sold.
Based on aggregated 13F filings for Q2 2025.